Antares Pharma (ATRS) Reports In-Line Q1 Loss of 3c/Share

May 8, 2013 7:52 AM

Antares Pharma (NASDAQ: ATRS) reported Q1 EPS of ($0.03) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found